AMVUTTRA

Approval Id: fba524111cfdcebb
Drug Approval Canada Name: AMVUTTRA
Product Name: AMVUTTRA
Status: Marketed
Status Date: 2023-12-15
Original Market Date: 2023-12-15
Din: 02542420
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 92:92.00
Atc Original: N07XX18 VUTRISIRAN
Atc Name: n 07 xx 18
Aig Number: 0165141001
Company Name: Alnylam Netherlands BV
Company Address: Antonio Vivaldistraat 150, Amsterdam, --, Netherlands, 1083 HP
Company Detail Path: /organization/alnylam-netherlands-bv

VUTRISIRAN (VUTRISIRAN SODIUM)

25 MG / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fba524111cfdcebb

Type

Standard